Lectra And Two Other Growth Stocks With High Insider Ownership On Euronext Paris

Amidst a backdrop of political uncertainty and fluctuating market conditions across Europe, investors are keenly watching the French market for signs of stability and growth potential. In this context, companies like Lectra that boast high insider ownership might offer a reassuring signal of confidence from those who know these companies best.

Top 10 Growth Companies With High Insider Ownership In France

Name	Insider Ownership	Earnings Growth
VusionGroup (ENXTPA:VU)	13.5%	25.2%
Groupe OKwind Société anonyme (ENXTPA:ALOKW)	24.8%	30.6%
La Française de l'Energie (ENXTPA:FDE)	20.1%	37.6%
Adocia (ENXTPA:ADOC)	12.1%	104.5%
OSE Immunotherapeutics (ENXTPA:OSE)	25.6%	79.3%
Icape Holding (ENXTPA:ALICA)	30.2%	26.1%
Arcure (ENXTPA:ALCUR)	21.4%	42.4%
Solutions 30 (ENXTPA:S30)	16.2%	102.6%
Munic (ENXTPA:ALMUN)	29.4%	150%
MedinCell (ENXTPA:MEDCL)	16.4%	74.6%

Click here to see the full list of 21 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

Let's explore several standout options from the results in the screener.

Lectra

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lectra SA, with a market cap of €1.04 billion, offers industrial intelligence solutions across the fashion, automotive, and furniture sectors in regions including Northern Europe, Southern Europe, the Americas, and Asia Pacific.

Operations: The company generates revenue from the Americas and Asia Pacific regions, totaling €170.33 million and €110.28 million respectively.

Insider Ownership: 19.6%

Earnings Growth Forecast: 28.6% p.a.

Lectra, a French growth company with high insider ownership, reported slightly decreased net income and earnings per share in Q1 2024 compared to the previous year. Despite this, Lectra is trading at 36.2% below its estimated fair value and is favorably valued relative to its peers. The company's revenue and earnings are expected to outpace the French market, with forecasts suggesting a revenue growth of 11.3% per year and earnings growth of 28.6% per year over the next three years. However, its Return on Equity is projected to be modest at 13.3%.

• Click here to discover the nuances of Lectra with our detailed analytical future growth report.

• Our comprehensive valuation report raises the possibility that Lectra is priced lower than what may be justified by its financials.

ENXTPA:LSS Ownership Breakdown as at Jun 2024

MedinCell

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a French pharmaceutical company specializing in the development of long-acting injectable medications across multiple therapeutic areas, with a market capitalization of approximately €378.37 million.

Operations: The company generates its revenue primarily from the pharmaceuticals segment, totaling €11.95 million.

Insider Ownership: 16.4%

Earnings Growth Forecast: 74.6% p.a.

MedinCell, a French biotech firm with significant insider ownership, faces challenges despite its growth potential. Recently, MedinCell reported a decrease in revenue and net loss improvement for the fiscal year ending March 2024. Key products like F14 showed mixed results in clinical trials but demonstrated some promising outcomes in secondary endpoints. Additionally, MedinCell's collaboration with AbbVie could bolster future prospects through co-development deals potentially worth up to €1.9 billion. The company is trading significantly below its estimated fair value and is expected to become profitable within three years, with projected high revenue growth outpacing the French market average.

• Click here and access our complete growth analysis report to understand the dynamics of MedinCell.

• Upon reviewing our latest valuation report, MedinCell's share price might be too pessimistic.

ENXTPA:MEDCL Earnings and Revenue Growth as at Jun 2024

OVH Groupe

Simply Wall St Growth Rating: ★★★★☆☆

Overview: OVH Groupe S.A. is a global provider of public and private cloud services, shared hosting, and dedicated server solutions, with a market capitalization of approximately €0.91 billion.

Operations: The company generates revenue through three primary segments: Public Cloud (€140.71 million), Private Cloud (€514.59 million), and Web Cloud (€179.45 million).

Insider Ownership: 10.5%

Earnings Growth Forecast: 101.5% p.a.

OVH Groupe, a key entity in the French tech sector with high insider ownership, is poised for notable growth. The company anticipates profitability within three years, supported by a robust annual earnings growth rate of 101.5%. Despite its revenue growth forecast of 10.9% per year lagging behind some market peers, it still outpaces the general French market's 5.8% expansion rate. Recent strategic executive appointments and operational enhancements underscore its commitment to innovation and international expansion, aligning with its development goals despite a volatile share price and modest forecasted return on equity of 3.7%.

• Delve into the full analysis future growth report here for a deeper understanding of OVH Groupe.

• Our valuation report unveils the possibility OVH Groupe's shares may be trading at a premium.

ENXTPA:OVH Ownership Breakdown as at Jun 2024

Next Steps

• Discover the full array of 21 Fast Growing Euronext Paris Companies With High Insider Ownership right here.

• Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.

• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include ENXTPA:LSS ENXTPA:MEDCL and ENXTPA:OVH.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com